These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 29558000

  • 21. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

  • 22. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.
    Szarvas N, Szilágyi Á, Tasic V, Nushi-Stavileci V, Sofijanova A, Gucev Z, Szabó M, Szabó A, Szeifert L, Reusz G, Rusai K, Arbeiter K, Müller T, Prohászka Z.
    Ital J Pediatr; 2014 Dec 11; 40():101. PubMed ID: 25496981
    [Abstract] [Full Text] [Related]

  • 23. Atypical hemolytic uremic syndrome.
    Loirat C, Frémeaux-Bacchi V.
    Orphanet J Rare Dis; 2011 Sep 08; 6():60. PubMed ID: 21902819
    [Abstract] [Full Text] [Related]

  • 24. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F.
    Pediatr Nephrol; 2013 Jan 08; 28(1):155-8. PubMed ID: 22956028
    [Abstract] [Full Text] [Related]

  • 25. [Atypical hemolytic uremic syndrome].
    Sepúlveda RA, Tagle R, Jara A.
    Rev Med Chil; 2018 Jun 08; 146(6):770-779. PubMed ID: 30148909
    [Abstract] [Full Text] [Related]

  • 26. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.
    Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, Rodriguez A, Salvador P, Seijo R, Pita S, Arjona E, Rodríguez de Córdoba S, Valdés Cañedo F.
    Am J Nephrol; 2018 Jun 08; 48(3):225-233. PubMed ID: 30205388
    [Abstract] [Full Text] [Related]

  • 27. Hemolytic uremic syndrome with multiple organ involvement secondary to complement factor H p.Arg1215X mutation.
    Yeşilbaş O, Şevketoğlu E, Petmezci MT, Kıhtır HS, Benzer M, Berdeli A.
    Turk J Pediatr; 2017 Jun 08; 59(5):576-580. PubMed ID: 29745120
    [Abstract] [Full Text] [Related]

  • 28. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM, Cugno M.
    Thromb Res; 2015 Nov 08; 136(5):851-4. PubMed ID: 26386489
    [Abstract] [Full Text] [Related]

  • 29. Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab.
    Yasuda S, Yamamoto M, Fukuda T, Ohtsuka Y, Miura O.
    Intern Med; 2016 Nov 08; 55(9):1171-5. PubMed ID: 27150874
    [Abstract] [Full Text] [Related]

  • 30. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 31. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
    Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D.
    J Korean Med Sci; 2016 Oct 29; 31(10):1516-28. PubMed ID: 27550478
    [Abstract] [Full Text] [Related]

  • 32. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
    Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A.
    Ther Apher Dial; 2019 Feb 29; 23(1):4-21. PubMed ID: 30294946
    [Abstract] [Full Text] [Related]

  • 33. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.
    Clin Exp Nephrol; 2019 Jan 29; 23(1):112-121. PubMed ID: 30039480
    [Abstract] [Full Text] [Related]

  • 34. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M, Rodríguez de Córdoba S, Campistol Plana JM.
    Med Clin (Barc); 2015 Nov 20; 145(10):438-45. PubMed ID: 25433773
    [Abstract] [Full Text] [Related]

  • 35. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C, Zaloszyc A, Licht C, Pichault V, Frémeaux-Bacchi V, Fischbach M.
    Pediatr Nephrol; 2016 Jan 20; 31(1):157-61. PubMed ID: 26399238
    [Abstract] [Full Text] [Related]

  • 36. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.
    Am J Kidney Dis; 2014 Jan 20; 63(1):40-8. PubMed ID: 24021908
    [Abstract] [Full Text] [Related]

  • 37. Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.
    Madden I, Roumenina LT, Langlois-Meurinne H, Guichoux J, Llanas B, Frémeaux-Bacchi V, Harambat J, Godron-Dubrasquet A.
    Pediatr Nephrol; 2019 Mar 20; 34(3):533-537. PubMed ID: 30560448
    [Abstract] [Full Text] [Related]

  • 38. Do not Miss Rare and Treatable Cause of Early-Onset Hemolytic Uremic Syndrome: Cobalamin C Deficiency.
    Topaloglu R, İnözü M, Gülhan B, Gürbüz B, Talim B, Coşkun T.
    Nephron; 2019 Mar 20; 142(3):258-263. PubMed ID: 31137025
    [Abstract] [Full Text] [Related]

  • 39. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
    Walsh PR, Johnson S, Brocklebank V, Salvatore J, Christian M, Kavanagh D.
    Am J Kidney Dis; 2018 Feb 20; 71(2):287-290. PubMed ID: 29248304
    [Abstract] [Full Text] [Related]

  • 40. Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
    Ferri M, Zotta F, Donadelli R, Dossier C, Duneton C, El-Sissy C, Fremeau-Bacchi V, Kwon T, Quadri L, Pasini A, Sellier-Leclerc AL, Vivarelli M, Hogan J.
    Pediatr Nephrol; 2024 Nov 20; 39(11):3263-3269. PubMed ID: 38632123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.